Regulatory role of phosphatidylinositol 3-kinase on TNF-α-induced cyclooxygenase 2 expression in colonic epithelial cells

Gastroenterology

Volumn 120, Issue 5, 2001, Pages 1117-1127

  Weaver, Sean A ^a   Russo, Maria Pia ^b   Wright, Karen L ^a   Kolios, George ^a   Jobin, Christian ^b   Robertson, Duncan A F ^c   Ward, Stephen G ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 4; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ARTICLE; COLON CANCER; COLON MUCOSA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHORESIS; ENTERITIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; EPITHELIUM CELL; GENE CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; WESTERN BLOTTING;

EID: 0035084463     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.23257     Document Type: Article

References (65)

1. Purification of the cyclo-oxygenase that forms prostaglandins. Demonstration of the two forms of iron in the holoenzyme
2. 2 synthase (cyclooxygenase) in human monocytes
3. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
4. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease
5. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease
6. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas
7. Role of prostaglandins in ulcerative colitis, enhanced production during active disease and inhibition by sulfasalazine
8. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease
9. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
10. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
11. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
12. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
13. Aspirin and the risk of colorectal cancer in women
14. Tumour necrosis factor and Crohn's disease
15. Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease
16. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group
17. Inhibition of proinflammatory molecule production by adenovirus- mediated expression of a NF-κB super-repressor in human intestinal epithelial cells
18. Specific NF-κB blockade selectively inhibits tumour necrosis factor-α-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells
19. Roles of phosphatidylinositol 3-kinase and Rac in the nuclear signaling by tumor necrosis factor-α in rat-2 fibroblasts
20. A novel pathway for tumor necrosis factor-α and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinase
21. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositol-3-OH kinase-dependent pathway
22. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
23. NF-κB is a target of Akt in anti-apoptotic PDGF signalling
24. Activation of NF-κB binding in HT-29 colon cancer cells by inhibition of phosphatidylinositol 3-kinase
25. Activation of phosphatidylinositol 3-kinase by interleukin-13 - An inhibitory signal for inducible nitric-oxide synthase expression in epithelial, cell line HT-29
26. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: Role of STAT6 and phosphatidylinositol 3′-kinase
27. Type 1 and type 2 cytokine regulation of macrophage endocytosis: Differential activation by IL-4/IL-13 as opposed to IFN-γ or IL-10
28. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells
29. The role of phosphoinositide 3-kinase lipid products in cell function
30. The tumour suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
31. PTEN: Sometimes taking it off can be better than putting it on
32. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway
33. Molecular classification of the inherited hamartoma polyposis syndromes: Clearing the muddied waters
34. Inherited mutations in PTEN that are associated with breast cancer, Cowden disease and juvenile polyposis
35. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps with Cowden disease
36. Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors
37. Colorectal carcinomas in mice lacking the catalytic subunit of PI3Kγ
38. Central role for G protein-coupled phosphoinositide 3-kinase in inflammation
39. Antiinflammatory activity of the new mold metabolite 11-desacetoxy-wortmannin and of some of its derivatives
40. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages
41. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
42. Direct and indirect modulation of ornithine decarboxylase and cyclooxygenase by UVB radiation in human skin cells
43. C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: Differential effect of T lymphocyte-derived cytokines
44. Inhibition of CD28-mediated T-cell co-stimulation by the
45. Evidence for altered regulation of I κ B α degradation in human colonic epithelial cells
46. The human colon carcinoma cell lines HT-29 and Caco-2: Two in vitro models for the study of intestinal differentiation
47. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin
48. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 Cells
49. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group
50. Cytokines and IBD
51. Lack of interleukin 10 regulation of antigen presentation-associated molecules expressed on colonic epithelial cells
52. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts
53. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes
54. Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages
55. Regulation of cyclooxygenase-2 expression in human mesangial cells - Transcriptional inhibition by IL-13
56. Signal transduction cascade in staurosporine-induced prostaglandin E2 production by rat peritoneal macrophages
57. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human endothelial cells
58. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes
59. A p38 map kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA
60. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells
61. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-κB activation
62. Tumor necrosis factor: Biology and therapeutic inhibitors
63. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
64. Inducible cyclooxygenase may have anti-inflammatory properties
65. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia